We are live on ! Find out more
AC

Aaron Cowen Suvretta Capital Management

AUM $5.47B
1-Year Est. Return 131.34%
 

Aaron Cowen is the founder of Suvretta Capital Management, a long/short equity firm with a fundamental research process. The firm invests across sectors with an emphasis on differentiated fundamental views. Cowen’s disclosures are tracked by investors who follow mid-to-large fundamental hedge funds.

This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+131.34%
3 Year Est. Return
+363.85%
5 Year Est. Return
+515.73%
10 Year Est. Return
+2,786.05%
AUM
$2.41B
AUM Growth
-$222M
Cap. Flow
-$88.5M
Cap. Flow %
-3.67%
Top 10 Hldgs %
36.65%
Holding
102
New
13
Increased
22
Reduced
25
Closed
29

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$92.7M
2
META icon
Meta Platforms (Facebook)
META
+$80.8M
3
TTWO icon
Take-Two Interactive
TTWO
+$66.6M
4
DIS icon
Walt Disney
DIS
+$61.6M
5
NOW icon
ServiceNow
NOW
+$57.9M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$92.5M
2
CNC icon
Centene
CNC
+$68.3M
3
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
+$63.9M
4
RPRX icon
Royalty Pharma
RPRX
+$52.8M
5
VTRS icon
Viatris
VTRS
+$40.6M

Sector Composition

Rank Sector Weight
1 Healthcare 45.65%
2 Industrials 13.65%
3 Consumer Discretionary 13.26%
4 Communication Services 10.93%
5 Technology 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRNX icon
76
Crinetics Pharmaceuticals
CRNX
$8.99B
– –
-1,125,112
Closed -$21M
CVX icon
77
Chevron
CVX
$403B
– –
-71,154
Closed -$10.3M
FIS icon
78
Fidelity National Information Services
FIS
$21.3B
– –
-443,240
Closed -$40.6M
HRMY icon
79
Harmony Biosciences
HRMY
$2.22B
– –
-58,734
Closed -$2.86M
HUM icon
80
Humana
HUM
$45.5B
– –
-197,668
Closed -$92.5M
IMRX icon
81
Immuneering
IMRX
$343M
– –
-200,000
Closed -$1.08M
MNST icon
82
Monster Beverage
MNST
$93.6B
– –
-999,208
Closed -$23.2M
MQ icon
83
Marqeta
MQ
$1.7B
– –
-865,926
Closed -$28.1M
MTCH icon
84
Match Group
MTCH
$9.38B
– –
-287,786
Closed -$20.1M
OXY icon
85
Occidental Petroleum
OXY
$61.3B
– –
-172,642
Closed -$10.2M
RH icon
86
RH
RH
$2.9B
– –
-133,325
Closed -$28.3M
ROIV icon
87
Roivant Sciences
ROIV
$26.2B
– –
-681,528
Closed -$2.77M
TERN
88
DELISTED
Terns Pharmaceuticals
TERN
– –
-1,238,800
Closed -$3.07M
TRDA icon
89
Entrada Therapeutics
TRDA
$295M
– –
-106,000
Closed -$1.29M
VTRS icon
90
Viatris
VTRS
$18.7B
– –
-3,881,900
Closed -$40.6M
XOM icon
91
ExxonMobil
XOM
$679B
– –
-290,732
Closed -$24.9M
CMRX
92
DELISTED
Chimerix, Inc.
CMRX
– –
-5,271,696
Closed -$11M
MRTX
93
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-951,986
Closed -$63.9M
OHAA
94
DELISTED
OPY Acquisition Corp. I Class A Common Stock
OHAA
– –
-200,000
Closed -$1.97M
CANO.WS
95
DELISTED
Cano Health, Inc. Redeemable Warrants, each whole warrant is exercisable for one-one hundredth (1/100th) of a share of Class A Common Stock at an exercise price of $1,150
CANO.WS
– –
-378,569
Closed -$257K
EUCR
96
DELISTED
Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR
– –
-99,999
Closed -$990K
EBAC
97
DELISTED
European Biotech Acquisition Corp. Class A Ordinary Shares
EBAC
– –
-300,000
Closed -$2.94M
OMEG
98
DELISTED
Omega Alpha SPAC Class A Ordinary Shares
OMEG
– –
-300,000
Closed -$2.96M
RACB
99
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
– –
-500,000
Closed -$4.9M
BLSA
100
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
– –
-200,000
Closed -$1.98M
1 2 3
4
5

Similar funds

NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Aaron Cowen's Q3 2022 Portfolio in Review

As of Q3 2022, Aaron Cowen held 102 positions worth $2.41B, down 8.4% from $2.63B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Aaron Cowen withdrew a net $88.5M in Q3 2022, closing 29 positions and reducing 25 holdings. Its most notable exit was Humana, an estimated $92.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 57% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Aaron Cowen opened a new position in Amazon worth $82.9M.

  • Aaron Cowen's largest Q3 2022 buy was Amazon: 733,460 shares worth $82.9M.
  • Aaron Cowen added most to Walt Disney in Q3 2022, an estimated $61.6M increase.
  • Aaron Cowen's biggest Q3 2022 reduction was Royalty Pharma, cutting an estimated $52.8M.
  • Aaron Cowen fully exited Humana in Q3 2022, selling an estimated $92.5M.
  • Aaron Cowen's ten largest holdings make up 37% of its $2.41B portfolio in Q3 2022.
  • Aaron Cowen opened 13 new positions and closed 29 in Q3 2022.
  • Aaron Cowen's portfolio value fell 8.4% quarter-over-quarter to $2.41B.

Based on Suvretta Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.